The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 2 sources its claims cite is checked for support yet.
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Open accessAbstract
The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death. BCL2 was isolated from the chromosomal breakpoint of follicular B-cell lymphoma. Transgenic mice that overexpress BCL2 display extended survival of resting B cells. In this study we use a monospecific anti-human BCL2 antibody to define the distribution of BCL2 protein within organized tissues. BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells. BCL2 is present in the surviving T cells in the thymic medulla. All hematopoietic lineages that derive from a renewing stem cell also display BCL2. A limited number of nonlymphoid tissues demonstrate BCL2 and can be grouped as (i) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, (ii) complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells, and (iii) long-lived postmitotic cells such as neurons. Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones. BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Using a monospecific anti-human BCL2 antibody, the authors map BCL2 protein across organized tissues and find it topographically restricted to long-lived or proliferating zones in tissues with apoptotic turnover. BCL2 is present in selected lymphoid, hematopoietic, glandular epithelial, complex epithelial, and postmitotic neuronal compartments.
Key findings
- Within germinal centers, BCL2 is restricted to the follicular mantle and portions of the light zone implicated in selection and maintenance of plasma cells and memory B cells.
- BCL2 is present in surviving T cells in the thymic medulla and in all hematopoietic lineages derived from a renewing stem cell.
- A limited set of nonlymphoid tissues shows BCL2: glandular epithelium regulated by hormones/growth factors, complex differentiating epithelium such as skin and intestine with long-lived stem cells, and long-lived postmitotic cells such as neurons.
- In tissues with apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones; the authors suggest BCL2 may confer longevity to progenitor and effector cells.
Methods
- The study uses a monospecific anti-human BCL2 antibody to define BCL2 protein distribution within organized tissues.
- The provided text does not report sample sizes, tissue sources, staining protocols, or quantitative analysis details.
Limitations
- The paper’s abstract does not state limitations.
- Evident from the provided text: only the abstract and reference list are available, so sample composition, antibody specificity controls, quantification, and full results cannot be assessed. No quantitative values are reported in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Own interpretation · 4 Own result · 2 No full text of the sources · 1 No basis given
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All hematopoietic lineages that derive from a renewing stem cell also display BCL2.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is present in the surviving T cells in the thymic medulla.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A limited number of nonlymphoid tissues demonstrate BCL2”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glandular epithelium in which hormones or growth factors regulate hyperplasia and involution”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“long-lived postmitotic cells such as neurons”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
In the paper
“Transgenic mice that overexpress BCL2 display extended survival of resting B cells.”
What the sources say
- Not checked — no full text of the sourcecites McDonnell et al., 1989 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
- It may state two separate claims as one. 1
In the paper
“The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.”
What the sources say
- Not checked — no full text of the sourcecites Hockenbery et al., 1990 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The anti-human BCL2 antibody used in this study is monospecific for BCL2.
“we use a monospecific anti-human BCL2 antibody”
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Self-citationBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
Cheng, H., & Leblond, C. P. (1974) · American Journal of Anatomy · doi:10.1002/aja.1001410407 · Cited by 1,737
Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113970 · Cited by 1,536
Cohen, J., & Duke, R. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.38 · Cited by 1,406
Regressive Events in Neurogenesis
Cowan, W. M., Fawcett, J. W., O'Leary, D. D. M., & Stanfield, B. B. (1984) · Science · doi:10.1126/science.6474175 · Cited by 1,316
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Self-citationCleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,177
Self-citation
Cited by
Sorted by citations
Items 401–500 of 1,244
Cheng, X., Tan, S., Duan, F., et al. (2019) · Breast Cancer · doi:10.1007/s12282-019-00980-5 · Cited by 70
Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
Xu, Y., McKenna, R. W., Molberg, K. H., et al. (2001) · American Journal of Clinical Pathology · doi:10.1309/j7rn-uxay-55gx-bunk · Cited by 70
The role of apoptosis (programmed cell death) in haemopoiesis and the immune system
Allen, P., Newland, A. C., & Bustin, S. A. (1993) · Blood Reviews · doi:10.1016/0268-960x(93)90025-y · Cited by 70
Differentiation-Dependent Expression of the BCL-2 Proto-Oncogene in the Human Trophoblast Lineage
Sakuragi, N., Matsuo, H., Coukos, G., Furth, E. E., Bronner, M. P., VanArsdale, C. M., Krajewsky, S., Reed, J. C., & Strauss, J. F. (1994) · Journal of the Society for Gynecologic Investigation · doi:10.1177/107155769400100212 · Cited by 70
Diffuse Large B-Cell Lymphoma of Bone
de Leval, L., Braaten, K. M., Ancukiewicz, M., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200309000-00011 · Cited by 69
“The expression of the antiapoptotic factor bcl-2 and of the surface adhesion molecule CD44 is normally downregulated at the GC stage of differentiation.(7,21,22,32) Bcl-2 protein is expressed by some GC-derived lymphomas because of a BCL-2-IgH translocation.”
BackgroundHarnessing the apoptotic programs in cancer stem‐like cells
Wang, Y., & Scadden, D. T. (2015) · EMBO Reports · doi:10.15252/embr.201439675 · Cited by 75
“Within the myeloid compartment, Bcl-2 is expressed in early myeloid progenitors but downregulated during myeloid differentiation, correlating with the short lifespan of mature myeloid cells [84].”
Johnston, S. R. D., MacLennan, K., Sacks, N. P. M., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00327-2 · Cited by 69
Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression
Davis, R. E., & Greenberg, P. L. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00051-4 · Cited by 69
Nakopoulou, L., Alexandrou, P. T., Stefanaki, K. S., Panayotopoulou, E. G., Lazaris, A. C., & Davaris, P. S. (2001) · Pathobiology · doi:10.1159/000064337 · Cited by 68
Li, X., Cheung, K. F., Ma, X., et al. (2011) · Oncogene · doi:10.1038/onc.2011.511 · Cited by 68
“BAX induces apoptotic cell death by cytokine deprivation and represses activity of BCL2, an apoptotic blocker (Hockenbery et al., 1991; Oltvai et al., 1993; Ruvolo et al., 2001).”
BackgroundEissa, S., & Seada, L. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.7.1423 · Cited by 68
Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation
Menéndez, P. R., Vargas, A., Bueno, C., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403231 · Cited by 68
Boyd, J. A., Takahashi, H., Waggoner, S. E., Jones, L. A., Hajek, R. A., Wharton, J. T., Liu, F.-S., Fujino, T., Barrett, J. C., & McLachlan, J. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3 · Cited by 103
Alterations of M�ller (glial) cells in dystrophic retinae of RCS rats
H�rtig, W., Grosche, J., Distler, C., et al. (1995) · Journal of Neurocytology · doi:10.1007/bf01179976 · Cited by 68
Tollenaar, R., van Krieken, J., van Slooten, H.-J., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.306 · Cited by 68
Immunohistochemical expression of BCL‐2 in melanomas and intradermal nevi
Saenz-Santamaria, M. C., Reed, J. A., McNutt, N. S., & Shea, C. R. (1994) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1994.tb00278.x · Cited by 67
“Normal proliferating cells have been reported to express BCIJ-2 (15, 17).”
BackgroundAccelerated disappearance of melanocytes in bcl-2-deficient mice.
Yamamura, K., Kamada, S., Ito, S., Nakagawa, K., Ichihashi, M., & Tsujimoto, Y. (1996) · PubMed · Cited by 67
Saegusa, M., Takano, Y., & Okayasu, I. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01225688 · Cited by 67
“It is widely accepted that bcl-2 down-regulates apoptosis (programmed cell death), contributing to embryogenesis and organ homeostasis (LeBrun et al. 1993; Hockenbery et al. 1991).”
BackgroundNew Approaches to the Treatment of Myelodysplasia
List, A. F. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-39 · Cited by 67
Sanz, C., Benito, A., Silva, M., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3199 · Cited by 67
“Cells expressing the CD34 surface antimyelocytes and myelocytes have been shown to express high gen constitute a heterogeneous population of hematopoietic levels of the apoptosis inhibitor Bcl-2, whereas metamyelo- cells that includes primitive, uncommitted stem/progenitor cytes display decreased expression and mature…”
BackgroundInverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma
Nakamura, S., Akazawa, K., Kinukawa, N., et al. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90061-1 · Cited by 67
Fish Oil Enhances Targeted Apoptosis During Colon Tumor Initiation in Part by Downregulating Bcl-2
Hong, M. Y., Chapkin, R. S., Davidson, L. A., et al. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4601_06 · Cited by 66
“Normally bcl-2 is expressed in the lower part of the colonic crypt (18,44,45), where spontaneous apoptosis is very low (7,15).”
BackgroundPrognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma*1
Viale, G., Roncalli, M. G., Grimelius, L., et al. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90082-9 · Cited by 66
Matsunaga, T., Iguchi, K., Nakajima, T., Koyama, I., Miyazaki, T., Inoue, I., Kawai, S.-I., Katayama, S., Hirano, K., Hokari, S., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5625 · Cited by 65
McOrist, S., Roberts, L., Jasni, S., et al. (1996) · Journal of Comparative Pathology · doi:10.1016/s0021-9975(96)80026-0 · Cited by 65
Ashwell, J. D., King, L. B., & Vacchio, M. S. (1996) · Stem Cells · doi:10.1002/stem.140490 · Cited by 65
Apoptosis and cutaneous biology
Raskin, C. A. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80266-6 · Cited by 64
Bcl-x expression influences keratinocyte cell survival but not terminal differentiation.
Pena, J. C., Fuchs, E. V., & Thompson, C. B. (1997) · PubMed · Cited by 65
Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.
Kondo, E., Yoshino, T., Yamadori, I., et al. (1994) · PubMed · Cited by 65
Wang, E., & Liu, D. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960101)60:1 · Cited by 8
Bcl-2 Slowsin VitroBreast Cancer Growth Despite Its Antiapoptotic Effect
Knowlton, K., Mancini, M., Creason, S. A., et al. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5277 · Cited by 64
Self-citationGangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors
Sung, C., Pearl, D. K., Coons, S. W., Scheithauer, B. W., Johnson, P. C., & Yates, A. J. (1994) · Cancer · doi:10.1002/1097-0142(19941201)74:11 · Cited by 38
Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1
Pathan, N., Aimé, C., Kitada, S., et al. (2001) · Neoplasia · doi:10.1038/sj.neo.7900213 · Cited by 64
Humphreys, R. A., Haist, J. V., Chakrabarti, S., Feng, Q., Arnold, J. M. O., & Karmazyn, M. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.2.h749 · Cited by 64
Merto, G. R., Cella, N., & Hynes, N. E. (1997) · PubMed · Cited by 64
Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl‐2 expression
Hoehner, J. C., Hedborg, F., Jernberg‐Wiklund, H., Olsen, L., & Påhlman, S. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620106 · Cited by 64
Induction of apoptosis before shedding of human intestinal epithelial cells
Grossmann, J., Walther, K., Artinger, M., et al. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04143-6 · Cited by 63
Kurotaki, H., Tsushima, Y., Nagai, K., & Yagihashi, S. (1999) · Acta Haematologica · doi:10.1159/000040984 · Cited by 63
“respectively. In hematological malignancies, most AML and chronic myelogenous leukemias (CML) in blast crisis are positive for bcl -2, whereas almost all CML are bcl -2-negative [”
BackgroundPrognostic significance of apoptosis and associated factors in oral squamous cell carcinoma
Stoll, C., Baretton, G. B., Ahrens, C., et al. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/pl00008207 · Cited by 63
“The preferential finding of bcl-2 in less welldifferentiated cells is commonly observed and obviously corresponds to the physiological function of bcl-2 protecting germinal tissue from demise by PCD [ 14 ].”
BackgroundKhanim, F. L., Mackett, M., Young, L. S., et al. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-11-2987 · Cited by 63
Sheu, L., Chen, A., Meng, C., et al. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90078-2 · Cited by 63
Age-dependent susceptibility to fatal encephalitis: alphavirus infection of neurons
Griffin, D. E., Levine, B., Tyor, W. R., et al. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9326-6_4 · Cited by 63
Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer
Kaklamanis, L., Savage, A. P., Whitehouse, R. M., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.310 · Cited by 63
From stem cells to lymphocytes; biology and transplantation
Aguila, H. L., Akashi, K., Domen, J., Gondy, K. L., Lagasse, E., Wright, D. E., Wassman, I. L., Morrison, S. J., Mebius, R. E., Shizuu, J., et al. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00971.x · Cited by 63
Dowd, D. R., & Miesfeld, R. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3600 · Cited by 63
Macklis, R. M., Beresford, B. A., Palayoor, S. T., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90391-8 · Cited by 63
Differential expression of APO‐1 on human thymocytes: Implications for negative selection?
Debatin, K., Süss, D., & Krammer, P. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240339 · Cited by 63
Granzyme B–Mediated Death of Pancreatic β-Cells Requires the Proapoptotic BH3-Only Molecule Bid
Estella, E., McKenzie, M. D., Catterall, T., et al. (2006) · Diabetes · doi:10.2337/db06-0129 · Cited by 62
“Bcl-2 and Bcl-XL have been observed in islet cells, which may account for their increased resistance (41,42).”
BackgroundFabbri, R., Venturoli, S., D’Errico, A., Iannascoli, C., Gabusi, E., Valeri, B., Seracchioli, R., & Grigioni, F. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00098-7 · Cited by 62
Ray, S. D., & Jena, N. (2000) · Archives of Toxicology · doi:10.1007/s002040050013 · Cited by 62
“In vivo, BCL-2 prevents many, but not all forms of apoptotic cell death that occur during lymphoid (Hockenbery et al. 1991; Miyashita and Reed 1993) development.”
BackgroundEarly cellular events in colorectal carcinogenesis
Renehan, A. G., O’Dwyer, S., Haboubi, N. Y., & Potten, C. S. (2002) · Colorectal Disease · doi:10.1046/j.1463-1318.2002.00336.x · Cited by 62
Mizuno, N., Yoshitomi, H., Ishida, H., et al. (1998) · Endocrinology · doi:10.1210/en.139.3.1429 · Cited by 62
Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
Bae-Jump, V. L., Jackson‐Cook, C. K., Maygarden, S. J., Plymate, S. R., Chen, J., & Ware, J. L. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980301)34:4 · Cited by 114
Bcl-2 Expression in Higher-grade Human Glioma: A Clinical and Experimental Study
Fels, C., Schäfer, C., Hüppe, B., Bahn, H., Heidecke, V., Kramm, C. M., Lautenschläger, C., & Rainov, N. G. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006484801654 · Cited by 62
“The 26 kD alpha form of bcl-2 protein, which has been predominantly studied, is localized on the mitochondrial membrane, nuclear membrane, and other cytoplasmic membranes [23,24].”
BackgroundSubir�, M., Mateo, J., Souto, J. C., Alt�s, A., & Fontcuberta, J. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199903)60:3 · Cited by 22
Scoggins, C. R., Meszoely, I. M., Wada, M., Means, A. L., Yang, L., & Leach, S. D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.4.g827 · Cited by 61
c-Myb is critical for murine colon development
Zorbas, M., Sicurella, C., Bertoncello, I., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202971 · Cited by 61
“In human colon crypts it is expressed in the proliferating region (Hockenbery et al., 1991; Lu et al., 1993).”
BackgroundPro-apoptotic effect of fluvastatin on human smooth muscle cells
Buemi, M., Allegra, A., Senatore, M., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00122-3 · Cited by 61
Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas
Walker, C. A., Robertson, L. J., Myskow, M. W., & Dixon, G. R. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.295 · Cited by 61
Proliferation and Apoptosis Within Juvenile Capillary Hemangiomas
Mancini, A. J., & Smoller, B. R. (1996) · American Journal of Dermatopathology · doi:10.1097/00000372-199610000-00009 · Cited by 60
Nakamura, T., Nomura, S., Sakai, T., et al. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90129-5 · Cited by 60
The Expression and Localization of bcl-2 Protein in Normal Skin and in Non-Melanoma Skin Cancers
Rodríguez‐Villanueva, J., Colome, M. I., Brisbay, S. M., & McDonnell, T. J. (1995) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80724-7 · Cited by 60
Survival factors and apoptosis
O’Connor, R. (1998) · Advances in biochemical engineering, biotechnology · doi:10.1007/bfb0102309 · Cited by 60
Rolink, A. G., & Melchers, F. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60499-x · Cited by 60
Ayhan, A., Yasui, W., Yokozaki, H., et al. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02400.x · Cited by 60
Borthwick, N., Bofill, M., Hassan, I., Panayiotidis, P. G., Janossy, G., Salmon, M., & Akbar, A. N. (1996) · PubMed · Cited by 60
Browne, S. J., Williams, A. C., Hague, A., et al. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590113 · Cited by 60
Campbell, K. L., McTiernan, A., Li, S. S., Sorensen, B. E., Yasui, Y., Lampe, J. W., King, I. B., Ulrich, C. M., Rudolph, R. E., Irwin, M. L., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0291 · Cited by 59
“Bcl-2 has been shown to prolong cell survival and to inhibit apoptosis (7, 8).”
BackgroundNew prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas
Hallermann, C., Niermann, C., Fischer, R., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.12.026 · Cited by 59
Chen, F., Yan, J.-J., Jin, Y., et al. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90289-0 · Cited by 59
π1 Binding Sites Are Negative Regulators of bcl -2 Expression in Pre-B Cells
Chen, H.-M., & Boxer, L. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3840 · Cited by 59
“Bcl-2 expression is diminished in germinal centers where apoptotic B-cell death is occurring (12, 30).”
BackgroundKuroki, T., Seki, S., Kawakita, N., Nakatani, K., Kitada, T., Sakaguchi, H., & Hisa, T. (1996) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192434 · Cited by 58
“ed to the absence of bcl-2 [15, 16] and the bcl-2 protein is”
BackgroundInterleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis.
Griffiths, S. D., GOODHEAD, D. T., Marsden, S. J., et al. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1789 · Cited by 59
Self-citationPiacentini, M., & Autuori, F. (1994) · Differentiation · doi:10.1046/j.1432-0436.1994.5710051.x · Cited by 59
Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.
Morris, C. B., Gendelman, R., Marrogi, A. J., et al. (1996) · PubMed · Cited by 59
What is the value of bcl‐2 protein detection for histopathologists?
Pezzella, F., & Gatter, K. C. (1995) · Histopathology · doi:10.1111/j.1365-2559.1995.tb00628.x · Cited by 59
Mitochondria as Functional Targets of Proteins Coded by Human Tumor Viruses
D’Agostino, D. M., Bernardi, P., Chieco‐Bianchi, L., & Ciminale, V. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)94003-7 · Cited by 59
Proteinase-activated Receptor 2 (PAR2) Decreases Apoptosis in Colonic Epithelial Cells
Iablokov, V., Hirota, C. L., Peplowski, M. A., Ramachandran, R., Mihara, K., Hollenberg, M. D., & MacNaughton, W. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610485 · Cited by 63
“The inflammatory bowel diseases (IBD)2, Crohn disease, and ulcerative colitis are chronic, debilitating conditions of the intestinal tract.”
BackgroundInfluentialBcl-2 oncoprotein expression in acute myeloid leukemia.
Bensi, L., Longo, R., Vecchi, A., et al. (1995) · PubMed · Cited by 58
Nucleolin Regulates Gene Expression in CD34-positive Hematopoietic Cells
Grinstein, E., Du, Y., Santourlidis, S., Christ, J., Uhrberg, M., & Wernet, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608068200 · Cited by 59
Casanovas, A., Ribera, J., Hukkanen, M., et al. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00461-0 · Cited by 58
Proliferation and Dna fragmentation in meningioma subtypes
Maier, H., Maier, H., Wanschitz, J., et al. (1997) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1997.00071.x · Cited by 58
bcl-2 protein in invasive ductal breast carcinomas
HURLIMANN, J., Vala, D. M., & Larrinaga, B. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192638 · Cited by 58
Hermo, L., Pelletier, R. ‐., Cyr, D. G., & Smith, C. E. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20785 · Cited by 58
“According to some investigators, high levels of BCL2 are not expressed in seminiferous tubules of adult rats (Hockenbery et al., 1991; Rodriguez et al., 1997).”
Venkataraman, G., McClain, K. L., Pittaluga, S., Rao, V. K., & Jaffe, E. S. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181d5ddf8 · Cited by 56
“model, juxtaposition of BCL2 besides the IGH enhancer region, leads to overexpression of BCL-2 and consequent lymphoma.(8,23) In mucosa associated lymphoid tissue lymphomas, translocation of API2 (gene coding for inhibitor of apoptosis protein-2) on chromosome 11, adjacent to the mucosa associated lymphoid tissue 1 on…”
BackgroundOthman, N., & Nagoor, N. H. (2014) · BioMed Research International · doi:10.1155/2014/318030 · Cited by 57
“The expression level of BCL-2 differs for different cell types; however high levels and aberrant patterns of BCL-2 expression were reported in a wide variety of human cancers, including lung cancer [50].”
BackgroundMechanistic Concepts in Androgen-dependence of Prostate Cancer
Craft, N., & Sawyers, C. (2004) · Cancer Metastasis Review · doi:10.1023/a:1006141806801 · Cited by 58
“Bcl-2, an inhibitor of apoptosis in many types of tumors, is expressed in a subset of the basal epithelial cells but not in the secretory epithelial cells of the normal prostate [43,44].”
BackgroundApoptosis and Predisposition To Oral Cancer
Polverini, P., & Nor, J. E. (1999) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411990100020201 · Cited by 57
Reversible Disruption of Thymic Function by Steroid Treatment
Kong, F.-K., Chen, C.-L. H., & Cooper, M. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6500 · Cited by 59
Sugerman, P. B., Joseph, B. K., & Savage, N. W. (1995) · Oral Diseases · doi:10.1111/j.1601-0825.1995.tb00181.x · Cited by 57
Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis.
Ray, S., & Diamond, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5548 · Cited by 57
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver
de Boer, C. J., van Krieken, J. H., Rhijn, C. M. J., & Litvinov, S. V. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2 · Cited by 237
Cell proliferation in dysplasia of the prostate: Analysis by PCNA immunostaining
McNeal, J. E., Haillot, O., & Yemoto, C. (1995) · The Prostate · doi:10.1002/pros.2990270505 · Cited by 57
Takenaka, K., Nagafuji, K., HARADA, M., Mizuno, S.-I., Miyamoto, T., Makino, S., Gondo, H., Okamura, T., & Niho, Y. (1996) · Blood · doi:10.1182/blood.v88.8.2871.bloodjournal8882871 · Cited by 55
Trophic mechanisms regulate mitotic neuronal precursors: role of vasoactive intestinal peptide (VIP)
Pincus, D. W., DiCicco-Bloom, E. M., & Black, I. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)90461-8 · Cited by 57
Ellison, D. W., Steart, P. V., Gatter, K. C., et al. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01070.x · Cited by 57
Seko, Y., Takahashi, N., Yagita∥, H., Okumura, K., Azuma, M., & Yazaki, Y. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199905)188:1 · Cited by 9
Straatsburg, I. H., Boermeester, M. A., Houdijk, A. P. J., Frederiks, W. M., Wesdorp, R. I. C., van Leeuwen, P. A. M., & Noorden, C. J. F. V. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199605)179:1 · Cited by 12
Naccarato, A. G., Viacava, P., Vignati, S., et al. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050470 · Cited by 56
Non-Hodgkin's Lymphoma and Type of Tobacco Smoke
Stagnaro, E., Tumino, R., Parodi, S., et al. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.431.13.3 · Cited by 56
Metadata
- Authors
- Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-08-15
- Volume
- 88
- Issue
- 16
- Pages
- 6961-6965
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52213
- OpenAlex
- W1970629830
- Semantic Scholar
- d825dc162ad208c572711f59c9aa1c7974e89492
- Cited by
- 1,252
- References
- 40
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 12
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2, apoptosis, germinal center, light zone, plasma cells, memory B cells, thymic medulla, hematopoietic stem cells, tissue distribution, epithelial stem cells, follicular B-cell lymphoma, transgenic mice
- MeSH terms
- Adult, Bone Marrow, Breast, Cell Survival, Digestive System, Female, Humans, Immunoenzyme Techniques, Male, Neurons, Pancreas, Prostate, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Skin, Thymus Gland, Palatine Tonsil, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
